Transaction in Own Shares

 
TIDMNVOB 
 
Novo Nordisk A/S - Share repurchase programme 
 
On 2 February 2010 Novo Nordisk initiated its share repurchase programme in 
accordance with the provisions of the European Commission's regulation no 
2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules. 
 
Under the programme Novo Nordisk will repurchase B shares for an amount up to 
DKK 2.0 billion in the period from 2 February 2010 to 26 April 2010. 
 
 
Since the announcement as of 22 February 2010, the following transactions have 
been made under the programme: 
 
                   Number of    Average     Transaction value, 
                    shares   purchase price        DKK 
 
 Accumulated, last 1,305,000                       496,879,259 
 announcement 
 
 22 February 2010     85,000       396.5120         33,703,520 
 
 23 February 2010    155,000       389.5312         60,377,336 
 
 24 February 2010     91,000       391.8990         35,662,809 
 
 25 February 2010     90,000       387.4210         34,867,890 
 
 26 February 2010     85,000       386.0500         32,814,250 
 
 Accumulated under 1,811,000                       694,305,064 
 the programme 
 
 
With the transactions stated above, Novo Nordisk owns a total of 32,082,298 
treasury shares, corresponding to 5.2% of the share capital. The total amount of 
shares in the company is 620,000,000 including treasury shares. 
 
 
Novo Nordisk is a healthcare company and a world leader in diabetes care. In 
addition, Novo Nordisk has a leading position within areas such as haemostasis 
management, growth hormone therapy and hormone replacement therapy. Novo Nordisk 
manufactures and markets pharmaceutical products and services that make a 
significant difference to patients, the medical profession and society. With 
headquarters in Denmark, Novo Nordisk employs more than 29,300 employees in 76 
countries, and markets its products in 179 countries. Novo Nordisk's B shares 
are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed 
on the New York Stock Exchange under the symbol 'NVO'. For more information, 
visit novonordisk.com. 
 
 
Further information: 
 
 
 Media:                                  Investors: 
 
 
 Elin K Hansen                           Klaus Bülow Davidsen 
 
 Tel: [phone]                    Tel: [phone] 
 
 [e-mail]                     [e-mail] 
 <mailto:[e-mail]>            <mailto:[e-mail]> 
 
 
                                         Kasper Roseeuw Poulsen 
 
                                         Tel: [phone] 
 
                                         [e-mail] 
                                         <mailto:[e-mail]> 
 
 
 In North America:                       In North America: 
 
 Sean Clements                           Hans Rommer 
 
 Tel: [phone]                  Tel: [phone] 
 
 [e-mail]                    [e-mail] 
 <mailto:[e-mail]>           <mailto:[e-mail]> 
 
 
Company Announcement no 12 / 2010 
 
 
 
 
[HUG#1389574] 
 
 
 
 
 
    Company Announcement  no 12 2010: http://hugin.info/2013/R/1389574/347705.pdf